Xeris Pharmaceuticals Inc Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Xeris Pharmaceuticals Inc stock price up 0.265% on Monday
(Updated on May 06, 2024)
The Xeris Pharmaceuticals Inc stock price gained 0.265% on the last trading day (Monday, 6th May 2024), rising from $1.89 to $1.90. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.51% from a day low at $1.89 to a day high of $1.97. The price has risen in 4 of the last 10 days and is up by 6.46% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 238 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $2.57 million.
The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.84, a level that may pose a second chance to hit a runner. According to fan-theory $2.17 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XERS Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 11.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Xeris Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.94. On a fall, the stock will find some support from the short-term average at $1.81. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss for Xeris Pharmaceuticals Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.78 and $1.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Xeris Pharmaceuticals Inc finds support just below today's level at $1.78. If this is broken, then the next support from accumulated volume will be at $1.75 and $1.74.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0850 between high and low, or 4.51%. For the last week, the stock has had daily average volatility of 5.45%.
Our recommended stop-loss: $1.82 (-3.74%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (XERS) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Xeris Pharmaceuticals Inc to open at $1.92, and during the day (based on 14 day Average True Range), to move between $1.79 and $2.00, which gives a possible trading interval of +/-$0.101 (+/-5.34%) up or down from last closing price. If Xeris Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.67% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.78 (6.07%) than the resistance at $2.13 (12.40%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Xeris Pharmaceuticals Inc will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.120. We will update the financials statements for Xeris Pharmaceuticals Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 16.80% in the first trading day after earnings release.
Is Xeris Pharmaceuticals Inc stock A Buy?
Xeris Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.113 Hold/Accumulate Unchanged
Predicted Opening Price for Xeris Pharmaceuticals Inc of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| $1.92 ( 1.14%) | $1.90 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XERS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.00 | 5.63 % | |
| R2 | 1.97 | 3.92 % | ||
| R1 | 1.95 | 2.86 % | ||
| Current price: | 1.90 | |||
| Support | S1 | 1.88 | -0.570 % | |
| S2 | 1.86 | -1.63 % | ||
| S3 | 1.83 | -3.34 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.23 | 17.68 % | |
| R2 | 2.21 | 16.62 % | ||
| R1 | 2.13 | 12.40 % | ||
| Current price | 1.90 | |||
| Support | S1 | 1.78 | -6.07% | |
| S2 | 1.75 | -7.65% | ||
| S3 | 1.74 | -8.18% |
FAQ
Click here for our free guide on how to buy Xeris Pharmaceuticals Inc Stock.
